# Neurobiology of Treatment Responses in MDD

> **NCT03068247** · PHASE3 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Duloxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03068247
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-11
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Institution was unable to manufacture radiotracer that was central to the protocol. Study transferred to another institution.
- **Last updated:** 2023-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03068247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03068247, "Neurobiology of Treatment Responses in MDD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03068247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*